Gene Symbol | Gene ID | Gene Info |
---|---|---|
NR2F2
|
ENSG00000185551.8 | nuclear receptor subfamily 2 group F member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_96873303_96873527 | NR2F2 | 531 | 0.707900 | 0.89 | 1.4e-03 | Click! |
chr15_96873980_96874189 | NR2F2 | 138 | 0.942901 | 0.85 | 4.1e-03 | Click! |
chr15_96872856_96873301 | NR2F2 | 868 | 0.508173 | 0.63 | 7.1e-02 | Click! |
chr15_96874636_96874806 | NR2F2 | 775 | 0.534303 | 0.62 | 7.5e-02 | Click! |
chr15_96875667_96876080 | NR2F2 | 79 | 0.903647 | 0.60 | 8.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_13107353_13108160 | 0.71 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1104 |
0.3 |
chr14_96505776_96506430 | 0.69 |
C14orf132 |
chromosome 14 open reading frame 132 |
442 |
0.88 |
chr8_145925356_145925968 | 0.66 |
AF186192.5 |
|
5257 |
0.15 |
chr20_55204347_55205219 | 0.63 |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
425 |
0.81 |
chr1_64239758_64239982 | 0.63 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
156 |
0.97 |
chr11_69458516_69459047 | 0.63 |
CCND1 |
cyclin D1 |
2807 |
0.29 |
chr14_38064845_38065186 | 0.62 |
TTC6 |
tetratricopeptide repeat domain 6 |
37 |
0.95 |
chr10_119301299_119301493 | 0.60 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
434 |
0.57 |
chr22_34315378_34316336 | 0.60 |
LARGE |
like-glycosyltransferase |
469 |
0.83 |
chr19_49661333_49661989 | 0.60 |
TRPM4 |
transient receptor potential cation channel, subfamily M, member 4 |
562 |
0.58 |
chr19_18788780_18789048 | 0.58 |
CRTC1 |
CREB regulated transcription coactivator 1 |
5573 |
0.15 |
chr3_50193036_50193699 | 0.58 |
RP11-493K19.3 |
|
86 |
0.87 |
chr7_124404616_124404767 | 0.57 |
GPR37 |
G protein-coupled receptor 37 (endothelin receptor type B-like) |
990 |
0.67 |
chr8_12989314_12989523 | 0.56 |
DLC1 |
deleted in liver cancer 1 |
1565 |
0.46 |
chr22_37914692_37915408 | 0.56 |
CARD10 |
caspase recruitment domain family, member 10 |
197 |
0.92 |
chr2_220416605_220416756 | 0.56 |
ENSG00000265252 |
. |
2811 |
0.1 |
chr5_146888798_146889073 | 0.55 |
DPYSL3 |
dihydropyrimidinase-like 3 |
684 |
0.81 |
chr5_131593477_131594185 | 0.54 |
PDLIM4 |
PDZ and LIM domain 4 |
431 |
0.81 |
chr1_36591188_36591339 | 0.54 |
COL8A2 |
collagen, type VIII, alpha 2 |
442 |
0.78 |
chr1_214723618_214723885 | 0.53 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
815 |
0.74 |
chr7_19155713_19156221 | 0.53 |
TWIST1 |
twist family bHLH transcription factor 1 |
1328 |
0.36 |
chr22_46470676_46471172 | 0.53 |
RP6-109B7.4 |
|
5153 |
0.11 |
chr19_3061066_3061410 | 0.53 |
AES |
amino-terminal enhancer of split |
164 |
0.92 |
chr11_62308348_62308681 | 0.53 |
RP11-864I4.3 |
|
3730 |
0.11 |
chr10_123872502_123872999 | 0.52 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
196 |
0.97 |
chr6_3749707_3750198 | 0.52 |
RP11-420L9.5 |
|
1393 |
0.41 |
chr2_189156791_189157404 | 0.51 |
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
330 |
0.89 |
chr2_45396710_45397149 | 0.51 |
SIX2 |
SIX homeobox 2 |
160360 |
0.04 |
chr11_115630420_115630914 | 0.51 |
ENSG00000239153 |
. |
132764 |
0.06 |
chr7_155006231_155006400 | 0.51 |
AC099552.4 |
Uncharacterized protein |
16169 |
0.2 |
chrX_73639854_73640301 | 0.51 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
1008 |
0.55 |
chr10_112290027_112290231 | 0.51 |
DUSP5 |
dual specificity phosphatase 5 |
32533 |
0.13 |
chr10_33625311_33625537 | 0.50 |
NRP1 |
neuropilin 1 |
234 |
0.96 |
chr2_75787847_75788044 | 0.50 |
EVA1A |
eva-1 homolog A (C. elegans) |
94 |
0.97 |
chr11_60692021_60692537 | 0.50 |
TMEM132A |
transmembrane protein 132A |
326 |
0.6 |
chr19_7293230_7293452 | 0.50 |
INSR |
insulin receptor |
601 |
0.74 |
chr15_42070037_42070369 | 0.50 |
MAPKBP1 |
mitogen-activated protein kinase binding protein 1 |
3303 |
0.16 |
chr19_3094656_3095580 | 0.50 |
GNA11 |
guanine nucleotide binding protein (G protein), alpha 11 (Gq class) |
710 |
0.53 |
chr17_40827580_40827731 | 0.49 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
1314 |
0.23 |
chr5_74348957_74349108 | 0.48 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
22308 |
0.25 |
chr10_33625756_33625907 | 0.48 |
NRP1 |
neuropilin 1 |
641 |
0.8 |
chr4_122301470_122301703 | 0.48 |
QRFPR |
pyroglutamylated RFamide peptide receptor |
248 |
0.94 |
chr11_60609533_60610326 | 0.48 |
CCDC86 |
coiled-coil domain containing 86 |
385 |
0.51 |
chr4_76480664_76481053 | 0.48 |
C4orf26 |
chromosome 4 open reading frame 26 |
400 |
0.86 |
chr4_157997002_157997188 | 0.48 |
GLRB |
glycine receptor, beta |
114 |
0.97 |
chr1_94146033_94146363 | 0.47 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
728 |
0.75 |
chr9_33264203_33264587 | 0.47 |
BAG1 |
BCL2-associated athanogene |
162 |
0.82 |
chr5_82767498_82767846 | 0.47 |
VCAN |
versican |
62 |
0.99 |
chr2_151342879_151343387 | 0.47 |
RND3 |
Rho family GTPase 3 |
1048 |
0.71 |
chr2_218808290_218808479 | 0.47 |
TNS1 |
tensin 1 |
409 |
0.87 |
chr7_130594422_130594573 | 0.47 |
ENSG00000226380 |
. |
32199 |
0.2 |
chr21_28215844_28216573 | 0.47 |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
112 |
0.98 |
chr1_27928266_27928441 | 0.46 |
AHDC1 |
AT hook, DNA binding motif, containing 1 |
1749 |
0.3 |
chr5_73839584_73839978 | 0.46 |
HEXB |
hexosaminidase B (beta polypeptide) |
96067 |
0.08 |
chr5_126625896_126626411 | 0.46 |
MEGF10 |
multiple EGF-like-domains 10 |
370 |
0.91 |
chr17_38600759_38601009 | 0.46 |
IGFBP4 |
insulin-like growth factor binding protein 4 |
1171 |
0.39 |
chr9_124497903_124498157 | 0.46 |
DAB2IP |
DAB2 interacting protein |
7034 |
0.28 |
chr10_128077385_128077536 | 0.46 |
ADAM12 |
ADAM metallopeptidase domain 12 |
436 |
0.89 |
chr16_839466_839674 | 0.46 |
CHTF18 |
CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae) |
257 |
0.75 |
chr14_54687052_54687326 | 0.45 |
CDKN3 |
cyclin-dependent kinase inhibitor 3 |
176484 |
0.03 |
chr11_75274557_75274740 | 0.45 |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
181 |
0.93 |
chr10_135186265_135186418 | 0.45 |
ECHS1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
852 |
0.3 |
chr4_25915833_25916134 | 0.45 |
SMIM20 |
small integral membrane protein 20 |
52 |
0.98 |
chr6_110721176_110721373 | 0.45 |
DDO |
D-aspartate oxidase |
15491 |
0.18 |
chr7_42275396_42275690 | 0.45 |
GLI3 |
GLI family zinc finger 3 |
1069 |
0.7 |
chr14_104178078_104178305 | 0.45 |
XRCC3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
250 |
0.68 |
chrX_102862587_102862757 | 0.44 |
TCEAL3 |
transcription elongation factor A (SII)-like 3 |
162 |
0.92 |
chr10_49812202_49812558 | 0.44 |
ARHGAP22 |
Rho GTPase activating protein 22 |
617 |
0.77 |
chr2_205410516_205411018 | 0.44 |
PARD3B |
par-3 family cell polarity regulator beta |
44 |
0.99 |
chr3_140770445_140770639 | 0.44 |
SPSB4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
298 |
0.93 |
chr17_15554007_15555167 | 0.43 |
RP11-640I15.1 |
|
317 |
0.52 |
chr3_64670816_64671530 | 0.43 |
ADAMTS9-AS2 |
ADAMTS9 antisense RNA 2 |
369 |
0.87 |
chr19_51013661_51013846 | 0.43 |
JOSD2 |
Josephin domain containing 2 |
592 |
0.57 |
chr2_112897786_112897937 | 0.43 |
FBLN7 |
fibulin 7 |
1701 |
0.45 |
chr13_102568682_102568833 | 0.43 |
FGF14 |
fibroblast growth factor 14 |
238 |
0.95 |
chr5_172754207_172754714 | 0.43 |
STC2 |
stanniocalcin 2 |
596 |
0.75 |
chr1_229406887_229407131 | 0.43 |
RAB4A |
RAB4A, member RAS oncogene family |
130 |
0.95 |
chr20_42543692_42544110 | 0.43 |
TOX2 |
TOX high mobility group box family member 2 |
397 |
0.9 |
chr19_55881241_55881431 | 0.43 |
IL11 |
interleukin 11 |
405 |
0.62 |
chr1_241519736_241519957 | 0.43 |
RGS7 |
regulator of G-protein signaling 7 |
369 |
0.92 |
chr13_40177539_40177866 | 0.42 |
LHFP |
lipoma HMGIC fusion partner |
394 |
0.88 |
chr7_194025_194290 | 0.42 |
AC093627.12 |
|
23 |
0.96 |
chr5_82768204_82768925 | 0.42 |
VCAN |
versican |
820 |
0.75 |
chr2_158113918_158114875 | 0.42 |
GALNT5 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
286 |
0.93 |
chr5_172754839_172755250 | 0.42 |
STC2 |
stanniocalcin 2 |
12 |
0.98 |
chr12_53264228_53264379 | 0.42 |
KRT78 |
keratin 78 |
21427 |
0.12 |
chr7_562042_562272 | 0.42 |
PDGFA |
platelet-derived growth factor alpha polypeptide |
2224 |
0.31 |
chr11_70245277_70245996 | 0.42 |
CTTN |
cortactin |
989 |
0.33 |
chr2_110372582_110372802 | 0.42 |
SOWAHC |
sosondowah ankyrin repeat domain family member C |
781 |
0.46 |
chr11_65292927_65293752 | 0.41 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
455 |
0.69 |
chr12_125002282_125002834 | 0.41 |
NCOR2 |
nuclear receptor corepressor 2 |
282 |
0.95 |
chr5_2750019_2750705 | 0.41 |
IRX2 |
iroquois homeobox 2 |
1407 |
0.43 |
chr4_187491209_187491867 | 0.41 |
MTNR1A |
melatonin receptor 1A |
14817 |
0.17 |
chr8_22722358_22722612 | 0.41 |
RP11-87E22.2 |
|
13000 |
0.17 |
chr17_7256192_7256343 | 0.41 |
KCTD11 |
potassium channel tetramerization domain containing 11 |
1059 |
0.2 |
chr19_56989221_56989415 | 0.41 |
ZNF667 |
zinc finger protein 667 |
116 |
0.95 |
chr4_48988746_48988897 | 0.41 |
CWH43 |
cell wall biogenesis 43 C-terminal homolog (S. cerevisiae) |
165 |
0.96 |
chr8_13132829_13133895 | 0.41 |
DLC1 |
deleted in liver cancer 1 |
693 |
0.78 |
chr19_44144384_44144665 | 0.40 |
CADM4 |
cell adhesion molecule 4 |
533 |
0.58 |
chr1_52455185_52455420 | 0.40 |
RAB3B |
RAB3B, member RAS oncogene family |
1134 |
0.37 |
chr6_84743193_84743395 | 0.40 |
MRAP2 |
melanocortin 2 receptor accessory protein 2 |
181 |
0.97 |
chr15_33010201_33010591 | 0.40 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
191 |
0.95 |
chr2_213401933_213402296 | 0.40 |
ERBB4 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
1139 |
0.66 |
chr18_8707466_8707765 | 0.40 |
RP11-674N23.1 |
|
4 |
0.73 |
chr5_139488272_139488632 | 0.40 |
LINC01024 |
long intergenic non-protein coding RNA 1024 |
237 |
0.9 |
chr11_65689542_65689693 | 0.40 |
DRAP1 |
DR1-associated protein 1 (negative cofactor 2 alpha) |
2422 |
0.13 |
chr16_49888604_49888984 | 0.40 |
ZNF423 |
zinc finger protein 423 |
1252 |
0.55 |
chr14_37132185_37132462 | 0.40 |
PAX9 |
paired box 9 |
544 |
0.76 |
chr2_151343410_151343893 | 0.40 |
RND3 |
Rho family GTPase 3 |
530 |
0.88 |
chrX_1570675_1570960 | 0.40 |
ASMTL |
acetylserotonin O-methyltransferase-like |
949 |
0.57 |
chr20_19738276_19738696 | 0.40 |
AL121761.2 |
Uncharacterized protein |
193 |
0.95 |
chr19_1844311_1844462 | 0.39 |
REXO1 |
REX1, RNA exonuclease 1 homolog (S. cerevisiae) |
4066 |
0.1 |
chr1_9750005_9750614 | 0.39 |
RP11-558F24.4 |
|
2696 |
0.25 |
chr16_1659932_1660093 | 0.39 |
IFT140 |
intraflagellar transport 140 homolog (Chlamydomonas) |
33 |
0.95 |
chr1_35247301_35247452 | 0.39 |
GJB3 |
gap junction protein, beta 3, 31kDa |
503 |
0.67 |
chr13_100636014_100636165 | 0.39 |
ZIC2 |
Zic family member 2 |
2063 |
0.31 |
chr8_141599151_141599550 | 0.39 |
AGO2 |
argonaute RISC catalytic component 2 |
16637 |
0.22 |
chr1_2981320_2981471 | 0.39 |
LINC00982 |
long intergenic non-protein coding RNA 982 |
1045 |
0.53 |
chr8_145162916_145163194 | 0.39 |
KIAA1875 |
KIAA1875 |
426 |
0.61 |
chr1_32180922_32181303 | 0.39 |
COL16A1 |
collagen, type XVI, alpha 1 |
11192 |
0.14 |
chrX_100740137_100740443 | 0.39 |
ARMCX4 |
armadillo repeat containing, X-linked 4 |
2741 |
0.23 |
chr4_6473021_6473172 | 0.38 |
PPP2R2C |
protein phosphatase 2, regulatory subunit B, gamma |
1077 |
0.64 |
chr11_70963000_70963203 | 0.38 |
SHANK2 |
SH3 and multiple ankyrin repeat domains 2 |
522 |
0.86 |
chr1_242687430_242687626 | 0.38 |
PLD5 |
phospholipase D family, member 5 |
292 |
0.95 |
chr3_66023514_66023733 | 0.38 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
360 |
0.9 |
chr1_43997540_43997756 | 0.38 |
PTPRF |
protein tyrosine phosphatase, receptor type, F |
1087 |
0.52 |
chr8_494269_494491 | 0.38 |
TDRP |
testis development related protein |
457 |
0.88 |
chr1_16472641_16472879 | 0.38 |
RP11-276H7.2 |
|
8946 |
0.12 |
chr10_115827778_115827973 | 0.38 |
ADRB1 |
adrenoceptor beta 1 |
24069 |
0.18 |
chr11_706564_706815 | 0.38 |
EPS8L2 |
EPS8-like 2 |
60 |
0.94 |
chr3_55520023_55520469 | 0.38 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
1085 |
0.48 |
chr17_46619346_46620019 | 0.38 |
HOXB-AS1 |
HOXB cluster antisense RNA 1 |
1231 |
0.24 |
chr10_21783539_21783739 | 0.38 |
ENSG00000222071 |
. |
1931 |
0.22 |
chr20_50104368_50104566 | 0.38 |
ENSG00000266761 |
. |
34953 |
0.19 |
chr6_80656707_80657785 | 0.38 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
51 |
0.98 |
chr8_49468858_49469448 | 0.38 |
RP11-770E5.1 |
|
5026 |
0.35 |
chr19_36164048_36164606 | 0.38 |
UPK1A-AS1 |
UPK1A antisense RNA 1 |
134 |
0.9 |
chr4_187765993_187766245 | 0.38 |
ENSG00000252382 |
. |
12491 |
0.3 |
chr10_88728773_88729195 | 0.38 |
ENSG00000272734 |
. |
49 |
0.52 |
chr20_43966885_43967036 | 0.38 |
SDC4 |
syndecan 4 |
10104 |
0.12 |
chr4_30723815_30723966 | 0.37 |
PCDH7 |
protocadherin 7 |
87 |
0.98 |
chr4_121843603_121843988 | 0.37 |
PRDM5 |
PR domain containing 5 |
209 |
0.96 |
chr5_146888436_146888745 | 0.37 |
DPYSL3 |
dihydropyrimidinase-like 3 |
1029 |
0.68 |
chr4_7940690_7941146 | 0.37 |
AC097381.1 |
|
190 |
0.86 |
chr6_121758735_121759079 | 0.37 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
2069 |
0.31 |
chr20_56284469_56284624 | 0.37 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
270 |
0.94 |
chr7_73133202_73133898 | 0.37 |
STX1A |
syntaxin 1A (brain) |
411 |
0.72 |
chr16_73089117_73089515 | 0.37 |
ZFHX3 |
zinc finger homeobox 3 |
4281 |
0.27 |
chr10_79396329_79396588 | 0.37 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
747 |
0.74 |
chr22_29704652_29704931 | 0.37 |
GAS2L1 |
growth arrest-specific 2 like 1 |
1743 |
0.22 |
chr7_73082725_73083354 | 0.37 |
VPS37D |
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
816 |
0.48 |
chr3_47051058_47051537 | 0.37 |
NBEAL2 |
neurobeachin-like 2 |
4526 |
0.22 |
chr1_63156195_63156408 | 0.37 |
RP11-230B22.1 |
|
2148 |
0.29 |
chr5_139422038_139422489 | 0.37 |
NRG2 |
neuregulin 2 |
391 |
0.85 |
chr12_56115218_56115698 | 0.36 |
RDH5 |
retinol dehydrogenase 5 (11-cis/9-cis) |
1261 |
0.23 |
chr18_7566824_7567068 | 0.36 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
166 |
0.97 |
chr3_62859521_62859700 | 0.36 |
CADPS |
Ca++-dependent secretion activator |
1094 |
0.63 |
chr3_50203978_50204129 | 0.36 |
ENSG00000207922 |
. |
6706 |
0.12 |
chr12_85306729_85307091 | 0.36 |
SLC6A15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
255 |
0.96 |
chr15_37390103_37390360 | 0.36 |
MEIS2 |
Meis homeobox 2 |
272 |
0.88 |
chr10_13932641_13932819 | 0.36 |
FRMD4A |
FERM domain containing 4A |
31818 |
0.2 |
chr12_132627637_132627788 | 0.36 |
DDX51 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 |
1168 |
0.35 |
chr22_46262805_46262956 | 0.36 |
ATXN10 |
ataxin 10 |
73404 |
0.09 |
chr19_41725635_41725911 | 0.36 |
AXL |
AXL receptor tyrosine kinase |
633 |
0.58 |
chr1_20811158_20811808 | 0.36 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
1230 |
0.48 |
chrY_1520685_1520965 | 0.36 |
NA |
NA |
> 106 |
NA |
chr17_48130853_48131004 | 0.36 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
2411 |
0.22 |
chr11_101454308_101454534 | 0.36 |
TRPC6 |
transient receptor potential cation channel, subfamily C, member 6 |
184 |
0.97 |
chr19_33554833_33554984 | 0.35 |
RHPN2 |
rhophilin, Rho GTPase binding protein 2 |
886 |
0.57 |
chr12_679488_679709 | 0.35 |
RP5-1154L15.2 |
|
16054 |
0.13 |
chr19_40972554_40972858 | 0.35 |
SPTBN4 |
spectrin, beta, non-erythrocytic 4 |
420 |
0.65 |
chr14_105439152_105439360 | 0.35 |
AHNAK2 |
AHNAK nucleoprotein 2 |
5438 |
0.17 |
chr7_27169583_27169809 | 0.35 |
HOXA-AS3 |
HOXA cluster antisense RNA 3 |
100 |
0.49 |
chr2_11051733_11051998 | 0.35 |
KCNF1 |
potassium voltage-gated channel, subfamily F, member 1 |
198 |
0.95 |
chr5_343772_343923 | 0.35 |
AHRR |
aryl-hydrocarbon receptor repressor |
204 |
0.94 |
chr16_121276_121527 | 0.35 |
RHBDF1 |
rhomboid 5 homolog 1 (Drosophila) |
1228 |
0.28 |
chr14_99712277_99712758 | 0.35 |
AL109767.1 |
|
16768 |
0.21 |
chr1_32042303_32042778 | 0.35 |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
401 |
0.75 |
chr10_26856365_26856519 | 0.35 |
ENSG00000199733 |
. |
57924 |
0.14 |
chr19_14606396_14606587 | 0.35 |
GIPC1 |
GIPC PDZ domain containing family, member 1 |
453 |
0.7 |
chr12_13025379_13025989 | 0.35 |
GPRC5A |
G protein-coupled receptor, family C, group 5, member A |
18032 |
0.14 |
chr13_100631982_100632133 | 0.35 |
ZIC2 |
Zic family member 2 |
1969 |
0.32 |
chr11_43965819_43966142 | 0.35 |
C11orf96 |
chromosome 11 open reading frame 96 |
1925 |
0.3 |
chr1_15733966_15734117 | 0.35 |
EFHD2 |
EF-hand domain family, member D2 |
2350 |
0.23 |
chr16_2208068_2208219 | 0.35 |
TRAF7 |
TNF receptor-associated factor 7, E3 ubiquitin protein ligase |
2377 |
0.09 |
chrX_107178963_107179207 | 0.34 |
RP6-191P20.4 |
|
125 |
0.97 |
chr1_33207592_33208218 | 0.34 |
KIAA1522 |
KIAA1522 |
419 |
0.8 |
chr3_49170609_49171370 | 0.34 |
LAMB2 |
laminin, beta 2 (laminin S) |
438 |
0.69 |
chr1_225960290_225960557 | 0.34 |
SRP9 |
signal recognition particle 9kDa |
5108 |
0.17 |
chr11_392852_393003 | 0.34 |
PKP3 |
plakophilin 3 |
313 |
0.79 |
chr19_6528847_6528998 | 0.34 |
TNFSF9 |
tumor necrosis factor (ligand) superfamily, member 9 |
2088 |
0.19 |
chrX_100740463_100741131 | 0.34 |
ARMCX4 |
armadillo repeat containing, X-linked 4 |
2234 |
0.26 |
chr1_162336853_162337007 | 0.34 |
C1orf226 |
chromosome 1 open reading frame 226 |
232 |
0.86 |
chr6_33384330_33384485 | 0.34 |
CUTA |
cutA divalent cation tolerance homolog (E. coli) |
1291 |
0.25 |
chr17_72889752_72889903 | 0.34 |
FADS6 |
fatty acid desaturase 6 |
119 |
0.93 |
chr17_79455455_79455747 | 0.34 |
ENSG00000266077 |
. |
22534 |
0.08 |
chr1_33190382_33190690 | 0.34 |
RP11-114B7.6 |
|
302 |
0.87 |
chr7_116167346_116167524 | 0.34 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
1088 |
0.46 |
chr19_4304677_4304951 | 0.34 |
FSD1 |
fibronectin type III and SPRY domain containing 1 |
128 |
0.91 |
chr19_1169038_1169260 | 0.34 |
SBNO2 |
strawberry notch homolog 2 (Drosophila) |
207 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.3 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.2 | 0.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.6 | GO:0009648 | photoperiodism(GO:0009648) |
0.2 | 0.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.7 | GO:0072070 | loop of Henle development(GO:0072070) |
0.2 | 0.5 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) positive regulation of cardiocyte differentiation(GO:1905209) |
0.2 | 0.3 | GO:0060463 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.2 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 | 0.3 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.2 | 0.5 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.4 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.1 | GO:0060044 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 0.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.6 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) |
0.1 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 0.6 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.3 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.2 | GO:1905207 | negative regulation of heart induction by canonical Wnt signaling pathway(GO:0003136) negative regulation of cardioblast cell fate specification(GO:0009997) cardioblast cell fate commitment(GO:0042684) cardioblast cell fate specification(GO:0042685) regulation of cardioblast cell fate specification(GO:0042686) regulation of cardioblast differentiation(GO:0051890) negative regulation of cardioblast differentiation(GO:0051892) cardiac cell fate specification(GO:0060912) negative regulation of heart induction(GO:1901320) regulation of cardiocyte differentiation(GO:1905207) negative regulation of cardiocyte differentiation(GO:1905208) regulation of cardiac cell fate specification(GO:2000043) negative regulation of cardiac cell fate specification(GO:2000044) |
0.1 | 1.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0071501 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.3 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.1 | 0.4 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.1 | 0.2 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.1 | GO:0090050 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) regulation of sprouting angiogenesis(GO:1903670) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.3 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.1 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.1 | 0.1 | GO:0032353 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.1 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.8 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.3 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.1 | 0.3 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.1 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.9 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.5 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.3 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.1 | GO:0043301 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 0.2 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.2 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.1 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.2 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.3 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.3 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.6 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.2 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of ion transmembrane transport(GO:0034766) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.6 | GO:1901222 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.2 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.3 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.2 | GO:0090502 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.4 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.0 | 0.1 | GO:0009151 | purine deoxyribonucleotide metabolic process(GO:0009151) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.2 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.0 | 0.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.1 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.0 | GO:0033860 | obsolete regulation of natriuresis(GO:0003078) regulation of NAD(P)H oxidase activity(GO:0033860) steroid hormone secretion(GO:0035929) corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.3 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.4 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.0 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.8 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.0 | 0.0 | GO:0048645 | organ formation(GO:0048645) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.4 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.5 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.7 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.2 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.0 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.1 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 0.0 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.0 | GO:0010523 | negative regulation of calcium ion transport into cytosol(GO:0010523) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.0 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.0 | 0.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.0 | 0.3 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.0 | 0.0 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.3 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.0 | 0.0 | GO:0032106 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.2 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.0 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.2 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.2 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.0 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.0 | 0.0 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.0 | 0.0 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0043096 | purine ribonucleoside salvage(GO:0006166) adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 2.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.0 | GO:0090075 | relaxation of smooth muscle(GO:0044557) negative regulation of smooth muscle contraction(GO:0045986) relaxation of vascular smooth muscle(GO:0060087) relaxation of muscle(GO:0090075) |
0.0 | 0.3 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.0 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.3 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.0 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.0 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.1 | GO:0071385 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 0.0 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.4 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.1 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:2000272 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) negative regulation of receptor activity(GO:2000272) |
0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0070509 | calcium ion import(GO:0070509) |
0.0 | 0.6 | GO:0030198 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.0 | 0.1 | GO:0042312 | regulation of vasodilation(GO:0042312) |
0.0 | 0.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.4 | GO:0060173 | appendage development(GO:0048736) limb development(GO:0060173) |
0.0 | 0.2 | GO:0046068 | cGMP metabolic process(GO:0046068) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.0 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0001942 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.0 | GO:0018198 | peptidyl-cysteine modification(GO:0018198) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.0 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 0.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.0 | 0.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.1 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.0 | GO:0031639 | plasminogen activation(GO:0031639) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.3 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 2.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 2.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.2 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 2.7 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 2.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 2.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 1.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 5.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.4 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.1 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 1.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 1.0 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.0 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 2.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.0 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.3 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.2 | 1.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 0.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.2 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.8 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 2.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 1.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.3 | GO:0070717 | poly(A) binding(GO:0008143) poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 2.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.4 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0046980 | tapasin binding(GO:0046980) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.6 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.2 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 1.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 4.4 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0030295 | protein kinase activator activity(GO:0030295) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.0 | 0.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.5 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 1.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 3.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 2.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.4 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 2.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 1.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |